trending Market Intelligence /marketintelligence/en/news-insights/trending/byGzUbSIn4fIczC8r9NYyA2 content esgSubNav
In This List

Kitov buys additional stake in TyrNovo

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Kitov buys additional stake in TyrNovo

Kitov Pharmaceuticals Holdings Ltd. acquired an additional 27% stake in TyrNovo Ltd. from unaffiliated minority shareholders for $7 million.

In exchange for the additional stake, Kitov will issue 13,169,689 new shares, or 658,484 American depositary shares, to the group of TyrNovo shareholders.

As a result of the transaction, Kitov now holds about 92% of TyrNovo's issued and outstanding shares. The company previously owned about 65% of TyrNovo.

TyrNovo is an Israel-based developer of novel small molecules in the oncology therapeutic field.